http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0193541-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd727aa2b4e6c347aadd94971881d671
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
filingDate 1987-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c35530b6eb4918765f66efc6d3f3f33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e2a5360b84c545a3d4911d06b86e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2d00120ffc42cca53ec8018120dc4b
publicationDate 1989-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0193541-A
titleOfInvention Drug composition
abstract PURPOSE: To obtain a drug composition having excellent absorption through mucosa and percutaneous absorption, showing high safety free from problems of biocompatibility, comprising a slightly soluble drug and water swelling clay minerals. n CONSTITUTION: A slightly soluble drug is dissolved in an organic solvent, into which natural or synthetic water swelling clay minerals (e.g. montmorillonite or hectorite), a lamellar silicate mineral belonging to the genus Smectite, is dispersed and sufficiently stirred. The organic solvent is removed, the residue is sufficiently dried to give a drug composition having the drug included in the water swelling clay minerals. The ratio of the clay minerals to the drug is preferably ≤40wt.% by weight. n COPYRIGHT: (C)1989,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5660860-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008530205-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011136922-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001278810-A
priorityDate 1987-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5821613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61155320-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6165807-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62116517-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450174003

Total number of triples: 25.